Acting on ethics and governance of aging research

被引:9
|
作者
Peng, Yaojin [1 ,2 ,3 ,4 ,5 ]
Ding, Lulu [1 ,4 ]
Song, Moshi [2 ,3 ,4 ,5 ,6 ]
Xiao, Zhenyu [7 ]
Lv, Jianwei [8 ]
Liu, Guang-Hui [2 ,3 ,4 ,5 ,6 ,9 ,10 ,11 ]
机构
[1] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China
[4] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China
[5] Aging Biomarker Consortium, Wuhan, Peoples R China
[6] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China
[7] Beijing Inst Technol, Sch Life Sci, Beijing, Peoples R China
[8] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China
[9] Capital Med Univ, Xuanwu Hosp, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China
[10] Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China
[11] Capital Med Univ, Xuanwu Hosp, Aging Translat Med Ctr, Int Ctr Aging & Canc,Beijing Municipal Geriatr Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.molmed.2023.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rapid advances in aging research and clinical translation come with numerous ethical and societal is-sues that the current regulatory framework may not be sufficient to address. To fill this gap, we pro-pose a responsible and compre-hensive governance framework to cope with these issues while maxi-mizing the benefits of aging re-search.
引用
收藏
页码:419 / 421
页数:3
相关论文
共 50 条